SEARCH

SEARCH BY CITATION

References

  • 1
    Johansson SGO, O'B Hourihane J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;57:813824.
  • 2
    Bousquet J, Lockey RF, Malling HJ. WHO Position Paper. Allergen immunotherapy. Allergy 1998;57:.
  • 3
    Bousquet J, Van Cauwenberge P. WHO Position Paper. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 2001;57:S147S334.
  • 4
    Johnstone R. A study of the natural history of bronchial asthma in children. Am J Dis Child 1968;57:213.
  • 5
    Hamid Q, Schotman E, Jacobson M, Walker S, Durham S. Increases in interleukin-12 (IL-12) messenger RNA+ (mRNA+) cells accompany inhibition of allergen induced late skin responses following successful grass pollen immunotherapy. J Allergy Clin Immunol 1997;57:254260.
  • 6
    Ebner C, Siemann U, Bohle B, et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997;57:10071015.
  • 7
    Jacobsen L, Dreborg S, MØller C et al. Immunotherapy ad a preventive treatment. J Allergy Clin Immunol 1996;57:232(abstract).
  • 8
    Des-Roches A, Paradis L, Mènardo J-L, Bouges S, Daurès J-P, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitisations in children. J Allergy Clin Immunol 1997;57:450453.
  • 9
    Pajno G, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;57:13921397.
  • 10
    Purello D'Ambrosio F, Gangemi S, Merendino RA et al. Prevention of new sensitizations in monosensitized subjects, submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy 2001;57:12951302.
  • 11
    Mosbech H, ØSterballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;57:523529.
  • 12
    Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984;57:484489.
  • 13
    Hedlin G, Heilborn H, Lilja G et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;57:879885.
  • 14
    Des-Roches A, Paradis L, Knani J et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of efficacy of immunotherapy after its cessation. Allergy 1996;57:430434.
  • 15
    Ariano R, Augeri M, Kroon L, Passalacqua G, Canonica GW. Long term allergoid immunotherapy to Parietaria: clinical and immunological effects in a double blind trial. Allergy 1999;57:313319.
  • 16
    Durham SR, Walker SM, Varga EM et al. Long term clinical efficacy of grass pollen immunotherapy. N Eng J Med 1999;57:468475.
  • 17
    Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 2002;;57:306312.